Beijing Molecule Science and Technology Co., Ltd.

Beijing Molecule Science Technology Co., Ltd.

Cuifang Lin

Cheng Xu

Lili Wang

Song Li

Junhai Xiao

Xinbo Zhou

Yunde Xie

Hao Cui

Hongying Liu

Chengmai Ruan

Wu Zhong

Zhibing Zheng

Zhong Wu

Zhibing Zhen

The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia 

Tyrosine derivatives substituted by N-arylacryloyl as agonists of hPPAR alpha and/or hPPAR gamma

The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia. 

Substituted &#x3b1;-piperazinyl phenylpropionic acid derivatives as hPPAR &#x3b1; and/or hPPAR &#x3b3; agonists

Growing community of inventors

Beijing, China

Cuifang Lin